Lab Essentials
AMPIVIEW® RNA probes
Enabling Your Projects 
GMP Services
Bulk Solutions
Research Travel Grant
Have You Published Using an Enzo Product?
Small Molecule Chemistry
| Alternative Name | N-Benzyl-3,5-dicarbethoxy-4-phenyl-1,4-dihydropyridine |
|---|---|
| CAS | 15301-69-6 |
| Couple Type | Activator |
| Purity | ≥98% (TLC) |
| Alternative Name | N-[(1-[4-(2-Oxo-3H-benzimidazol-1-yl)-piperidin-1-yl]-ethyl]quinoline-3-carboxamide |
|---|---|
| Couple Type | Inhibitor |
| Purity | ≥98% (TLC) |
| Alternative Name | N-(2-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)-ethyl)quinoline-3-carboxamide, VU0285655-1 |
|---|---|
| CAS | 1158347-73-9 |
| Couple Type | Inhibitor |
| Purity | ≥98% (TLC) |
| Alternative Name | N-Hydroxy-7-[5-(4-tertbutoxycarbonylaminophenyl)-3-isoxazolecarboxamido]heptanamide |
|---|---|
| CAS | 1045792-66-2 |
| Couple Type | Inhibitor |
| Purity | ≥98% (TLC) |
| Alternative Name | N-(3,4-Dichlorobenzyl)-5-bromoisatin O-acetyloxime |
|---|---|
| Couple Type | Inhibitor |
| Purity | ≥98% (TLC) |
| Alternative Name | NCGC00030335, 1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-ylsulfonyl)-4-(4-methoxyphenylsulfonyl)-piperazine |
|---|---|
| Couple Type | Activator |
| Purity | ≥98% (TLC) |
| Alternative Name | 2-Amino-4-[3,4-(methylenedioxy)benzylamino]-6-(3-methoxyphenyl)pyrimidine |
|---|---|
| CAS | 853220-52-7 |
| Couple Type | Activator |
| Purity | ≥98% (HPLC) |
| Alternative Name | 5-Methyl-6-oxo-N-(1,3,4-thiadiazol-2-yl)-7H-furo[2,3-f]indole-7-carboxamide |
|---|---|
| Couple Type | Inhibitor |
| Purity | ≥98% (TLC) |
| Alternative Name | Bis(maltolato)oxovanadium (IV) |
|---|---|
| CAS | 38213-69-3 |
| Couple Type | Inhibitor |
| Purity | ≥96% (TLC) |
| Alternative Name | 5-tert-Butoxycarbonyl-5-methyl-1-pyrroline-N-oxide |
|---|---|
| CAS | 387334-31-8 |
| Purity | ≥99% (HPLC) |
| Alternative Name | LIMKi 3, N-[5-[1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-2-thiazolyl]-2-methylpropanamide |
|---|---|
| CAS | 1338247-35-0 |
| Couple Type | Inhibitor |
| Purity | ≥98% (HPLC) |
